Cold chain logistics for clinical trials
Clinical Trials
Specialty Cold-Chain
Key takeaways
Qualification evidence must match the material, packout, route and duration used in the study.
Laboratory thermal testing and operational lane verification answer different questions.
An approved protocol defines acceptance criteria before testing starts.
End-to-end control includes conditioning, pickup, customs, receiving and change control.
Cold chain logistics for clinical trials requires documented validation that the planned transport process can maintain the required conditions for the study material. Cold chain validation connects packaging performance with the actual route, handling steps and receiving arrangements.
Cold chain logistics for clinical trials can involve investigational products, reference materials and specimens with very different requirements. Begin with the study's material-specific instructions, then qualify the process that will actually be used. A container's advertised duration is not, by itself, evidence for the whole journey.
Define the clinical trial transport requirements first
The sponsor and responsible quality or laboratory team should define the acceptable transport temperature, maximum elapsed time and relevant limits on light, vibration or orientation. Establish the starting condition and how suitability will be assessed at receipt.
Do not assign a generic frozen or refrigerated range to every clinical material. A biological sample's handling protocol can differ from an investigational medicine's stability-supported conditions. Similarly, a cryogenic process should not be described simply as anything below -80°C.
Map each handoff from material release through packout, pickup, staging, line-haul movement, border review and transfer into receiving storage. For inventory and site-allocation responsibilities beyond transport qualification, see Mercury's clinical supplies management guide.
Separate packaging qualification from route performance
Cold chain testing provides evidence about defined conditions. The following activities complement each other, but they are not interchangeable.
Activity | Question answered | Evidence needed |
|---|---|---|
Design assessment | Can the proposed system meet the product and distribution requirements? | Specifications, risk assessment and selected packout |
Controlled thermal qualification | Does the packout maintain conditions under selected challenge profiles? | Approved tests, calibrated measurements and results |
Lane or operational performance qualification | Does the complete process perform on representative routes? | Shipment records, temperature data and handoff evidence |
Ongoing verification and change control | Does the approved process remain suitable? | Routine review, deviations, changes and justified reassessment |
The WHO supplement on qualification of shipping containers describes a qualification framework and protocol elements. Apply it with the relevant quality system and product requirements rather than treating its examples as mandatory test counts for every trial.
Thermal performance is different from sterile-container integrity
A cold chain test for pharmaceuticals evaluates temperature-control performance under defined conditions. Container closure integrity testing addresses the barrier of the product container, such as a vial. One does not substitute for the other, and a thermal shipping protocol should not automatically prescribe every product-container test.
Build an approved cold chain transport validation protocol
A cold chain transport validation protocol should define the decision to be made before testing starts. Include the material or representative payload, required conditions, packout configuration, equipment, preparation steps, sensor locations, recording interval and acceptance criteria.
Describe the ambient profiles and transit durations being challenged, including a justified delay allowance. Minimum and maximum payloads, summer and winter exposure, orientation or handling can matter. Specify who executes the study, reviews the data, assesses deviations and approves the final report.
Cold chain shipping validation should leave enough detail to reproduce the approved configuration. Identify refrigerant conditioning, component quantities, assembly order and any reusable-system inspection requirements. Replacing insulation, coolant or payload arrangement should trigger a change assessment.
Select cold chain packaging for clinical trials
Choose the system against the material's conditions, shipment volume and route risks. Passive systems depend on qualified insulation and refrigerant preparation. Powered systems add dependencies such as battery duration, charging and equipment availability. The practical comparison belongs in Mercury's active and passive cold chain guide.
Packaging suppliers' qualification reports can support the process when the study conditions match their tested envelope. Check the actual report, including payload assumptions and sensor placement. Peli BioThermal's technical explanations of qualification durations illustrate why simplified website duration claims need to be checked against the underlying report.
Prove the process across the whole lane
Temperature-controlled clinical trial logistics includes the periods before collection and after arrival. A qualified box can still fail operationally if it waits unconditioned on a loading dock, misses export documentation or arrives at a site without suitable storage.
Before releasing the route, confirm:
Trained packout and receiving staff with the approved instructions.
Carrier acceptance, customs readiness and a realistic delivery window.
Monitoring activation, payload-relevant sensor placement and access to records.
Named contacts for delays and authorized intervention.
Documented receipt and condition review before material is released for use.
For home deliveries, use Mercury's direct-to-patient logistics guide for the additional recipient and privacy controls. Any out-of-limit record should enter the approved quality process, with the detailed response covered in the temperature excursion guide.
Maintain the evidence as the trial changes
New countries, depots, carriers, packouts or delivery patterns can change the process that was qualified. Review those changes before extending the original evidence to new conditions. Retain approved protocols, results, deviations, training records and the current shipping instructions together.
A defensible cold chain transport validation program makes the approved operating envelope clear and identifies when further assessment is needed. That keeps the trial's day-to-day shipments connected to the evidence supporting them.
